Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$190.52 - $236.72 $176,802 - $219,676
928 New
928 $215,000
Q4 2023

Feb 05, 2024

SELL
$222.59 - $267.94 $890 - $1,071
-4 Reduced 0.43%
924 $239,000
Q3 2023

Nov 07, 2023

BUY
$253.3 - $285.89 $10,132 - $11,435
40 Added 4.5%
928 $238,000
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $1,926 - $2,226
7 Added 0.79%
888 $252,000
Q1 2023

May 01, 2023

BUY
$256.56 - $292.34 $11,032 - $12,570
43 Added 5.13%
881 $244,000
Q4 2022

Jan 24, 2023

BUY
$252.44 - $306.72 $1,009 - $1,226
4 Added 0.48%
838 $0
Q3 2022

Oct 14, 2022

BUY
$194.69 - $268.46 $162,371 - $223,895
834 New
834 $223,000
Q4 2021

Jan 24, 2022

SELL
$223.92 - $287.77 $178,688 - $229,640
-798 Closed
0 $0
Q3 2021

Oct 15, 2021

SELL
$282.99 - $369.05 $2,546 - $3,321
-9 Reduced 1.12%
798 $226,000
Q2 2021

Jul 21, 2021

SELL
$259.0 - $414.71 $3,108 - $4,976
-12 Reduced 1.47%
807 $279,000
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $13,605 - $15,939
-56 Reduced 6.4%
819 $229,000
Q4 2020

May 12, 2021

BUY
$236.26 - $355.63 $206,727 - $311,176
875 New
875 $209,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Lcm Capital Management Inc Portfolio

Follow Lcm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lcm Capital Management Inc with notifications on news.